Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|June 26, 2014
Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell linesThomas Cluzeau, Alix Dubois, Arnaud Jacquel, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Oncotarget|May 12, 2012
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patientsThomas Cluzeau, Guillaume Robert, Nicolas Mounier, et al.
Oncotarget|November 5, 2017
Sirtuin 7: a new marker of aggressiveness in prostate cancerRomain Haider, Fabienne Massa, Lisa Kaminski, et al.
Oncotarget|December 15, 2012
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinibOphélie Cassuto, Maeva Dufies, Arnaud Jacquel, et al.
European Journal of Haematology|January 29, 2020
Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatmentAnne Calleja, Seongseok Yun, Chimène Moreilhon, et al.
BMC Palliative Care|October 16, 2022
Expert survey on coverage and characteristics of pediatric palliative care in Europe - a focus on home careJulia Wager, Larissa Alice Kubek, Maria Brenner, et al.
Pageof 9